Background: Tobacco cigarette smoking is on the decline, but the usage of electronic nicotine
INTRODUCTION
The use of electronic nicotine delivery systems (ENDS) has been proliferating. It was recently shown that among high school students, ENDS use increased from 1.5% in 2011 to 20 .8% in 2018 1 . Alarmingly, from 2017 to 2018 alone, there was a 75% increase in ENDS use by high school students 1 . The popularity of flavored ENDS likely fueled the proliferation of manufacturers, and the surge in sales of these products 2 . In 2014, it was estimated that there were more than 7600 different flavored ENDS products from 466 brands 3 , and as of this date, these numbers have only increased. The demand for ENDS continues to grow 4 as evident by a dynamic market 3, 5 which is projected to surpass $6 billion in the next couple of years.
However, the health effects and particularly, the cardiac toxicity of ENDS remain incompletely understood.
It has been argued that ENDS use might be less harmful in some ways compared to combustible tobacco cigarettes, however, ENDS products are not harm free. Data suggests that in young people, ENDS consumption instead of the traditional tobacco cigarettes paradoxically puts the user at a significantly greater risk of later initiation of combustible tobacco cigarette smoking 1, 6 .
Vaping is a form of electronic nicotine delivery, where the vaping device heats the "eliquid" via a coil, in order to generate "e-vapor", an inhalable smoke-like aerosolized mixture containing nicotine and flavors. E-liquids are usually a mixture of propylene glycol and vegetable glycerin, flavors, and either nicotine salt or free base nicotine. E-liquids can be used with different ENDS devices such as the pod-based system that requires the use of e-liquid with nicotine salt, or the tank-based vaping system, where a "tank" holds the e-liquid with free base nicotine. Both pod-based and tank-based systems are popular among different age groups 4 .
Several studies investigated the toxicity of e-liquids, and it was shown that flavoring aldehydes could be harmful in cell culture [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , however, the possible cardiac electrophysiological toxicity of vaping has not been systematically examined and is not completely understood. Here, we will assess the cardiac electrophysiological toxicity of 3 eliquids of different flavors and we will test the hypothesis that vaping results in cardiac electrophysiological instability and arrhythmogenesis.
METHODS

Vaping chamber:
A rat housing cage (Techniplast GR900) was modified, were the bottom was fitted for the introduction of the mouthpiece of Smok Species Baby V2, SMOKTech, vaping device. We used the Baby V2 A2 dual sub-coils with a total resistance of 0.2 ohms, at 85 Watts. An inlet and outlet openings were created in the cage's lid. The inlet opening was used to connect the mouthpiece via a plastic tube (Fisherbrand ¼ ID, 3/8 OD), to an air flow meter, 4 L/ minute (Western Medica), which in turn, was connected to a silent fish tank air pump. The outlet opening was fit with a plastic tube (Fisherbrand) that served as exhaust. A Universal High-powered Door Actuator (ZoneTech)-car door locking mechanism-was fixed alongside the vaping device, aimed at the device's firing button. The actuator was connected to an AC/DC power adapter. Both, the actuator's power adapter and the air pump were wired into the same cycle timer. Every 2 minutes, the cycle timer turns on for 5 seconds. This causes the actuator to push the vaping device's firing button, and simultaneously, air flows into the mouthpiece, expelling, for 4.7 seconds, an e-vapor puff at 4L/minute inside the cage. The vaping device touch screen displays the duration of the device's activation every time the firing button is pressed. A total of 60 puffs, over a 2-hour period was delivered. This is consistent with the topography of vaping in ENDS users, where studies indicated that users could engage in an average of 50 puffs per day [19] [20] [21] . Figure 1 A is the tank-based vaping device used, and B is a diagram the exposure system.
Exposure of animals to e-vapor:
The animals were exposed to 4.7 second puffs of e-vapor at 4L/minute, every 2 minutes for a total of 60 puffs in a 2-hour period. Mice were exposed 5 days a week, for a period of 10 weeks. Control mice experienced the same handling of the experimental animals and were placed in a similar modified chamber in the same environment where the only difference is that they were exposed to normal room air.
Preparation of e-vapor extracts:
A 10cm x 10cm x 7cm chamber was modified with a bottom opening fitted for the mouthpiece of the Smok Species Baby V2, SMOKTech, vaping device, and an inlet and outlet openings were introduced in the chamber's sealing top lid. The inlet tube was connected by plastic tubing (Fisherbrand) into the vaping device's mouthpiece and the flow meter and air pump, as done for the vaping cage above. The outlet was passed through the cap of a 50 ml conical tube containing cell culture media. Another tube was passed into the 50 mL conical tube cap and connected to a liquid trap flask, then to an air flow meter at 4L/ minute, and finally to a vacuum. Similar to the vaping machine, every 2 minutes, the cycle timer turns on for 5 seconds causing the actuator to push the vaping device's firing button, and simultaneously, air flows into the mouthpiece, expelling a 4.7 seconds e-vapor puff at 4L/minute inside the chamber. The vacuum pump draws the e-vapor from the chamber at 4L/minutes, leading to its bubbling into the medium. 10mL of medium was bubbled with 15 puffs of vapor, considered to be 100% e-vapor extract. For air control, the exact procedure was performed, however, the vaping device was powered off. Dilutions of e-vapor, or air extracts were then made with non-treated cell culture media. Figure 1C is Mass spectrometry: E-vapors were generated using the same setup described in Figure 1 .
The 10cm x 10cm x 7cm chamber was slightly altered, where the outlet tube was replaced with a septum. 5 puffs were generated, each for 4.7s at an interval of 10s, at a flow rate of 4 L/min.
Immediately after the smoke was generated, a 2.5mL Hamilton glass syringe was introduced through the septum to extract 250uL of e-vapor from the chamber. The smoke was then immediately injected manually into the Aglient 7890B GC-MS 5977B. The headspace syringe was cleaned between sample by rinsing repeatedly in pesticide grade methanol and then thoroughly dried in an incubator for 30mins at 70 C. The GC-MS parameters were optimized based on previous studies 17, 23 and are reported in Table 1 . MassHunter Workstation
Qualitative Analysis Software (Version B.07.00 SP2) in conjunction with NIST MS Search 2017
Library wereu sed for analysis. Peaks were identified based on a match score factor higher than 700. . Soon after the experiment was completed, media was gently removed, and 40µl of RIPA lysis buffer was added, and cells were lysed using a 1 ml syringe.
Protein concentration was quantified by BCA protein assay (Thermo Fisher Scientific) for normalization of the respiration parameters.
Telemetry and HRV analysis:
Wild type C56bl/6J (males and females,3 to 5 months of age),
were implanted with ECG telemetric devices (ETA-F10, DSI) using sterile equipment, under general anesthesia with 2% Isoflurane, and body temperature maintained at 37°C on with a heating pad. Manufacturer's recommendation for subcutaneous transmitter placement along the lateral flank were followed. The animals were allowed to recover for fourteen days after the implantation procedure. ECG recordings in freely moving animals, were done using the PhysioTel RPC-3 (DSI) receivers, after 1, 5, or 10 weeks of exposure to e-vapor. We compared cellular respiration in HL-1 cells after 24h treatment with 25% e-vapor from an e-liquid with a higher toxicity (apple jax, APJ) or lower toxicity (POG) as determined in significantly depressed with apple jax and POG treatment versus air, but maximal OCR was significantly lower in air versus apple jax only (one way ANOVA, Bonferroni correction, p<0.05). As a whole, this experiment suggests that flavored e-liquids impair the cardiac myocyte's respiratory process 24 and an e-liquid with a higher toxicity depresses the respiratory processes more that an e-liquid with a lower toxicity.
Next, we tested in spontaneously beating hiPSC derived ventricular cardiomyocytes, the effects of 5, 25 and 50% apple jax e-vapor extract or air on beating rate and field potential durations. hiPSC cardiomyocytes were seeded in 24 well multiple electrode array (MEA)
plates. Each well contains 16 electrodes in a 4x4 configuration, 100 μm interelectrode distance. The Presto Multielectrode Array was used to simultaneously record the 16 unipolar extracellular potentials in each well. Only wells that showed spontaneous activity were used.
50%
Apple Jax e-vapor completely suppressed the spontaneous beating of the cells, but not 50% air. Figure 5 A shows the electrograms recorded before and after treatment with 25%
Apple Jax e-vapor for 24 hours. 25% apple jax treatment for 24 hours accelerated the beating rate from 27 ± 1 in air control, to 60 ± 4 beats per minutes in apple jax (*p<0.01), and increased the field potential duration from 152.1 ± 10.1 ms in air to 270.6 ± 13.064 ms in evapor treated cells (*p<0.01). 5% apple jax e-vapor did not significantly affect beating rate or the field potential duration.
We investigated the effects of 10 weeks inhalation exposure to vanilla custard e-vapor, or air control, on heart rate variability parameters in wild type C56bl/6J mice instrumented with telemetric ECG. HRV parameters were measured at baseline, 1, 5, and 10 weeks exposure. 
DISCUSSION
Flavored ENDS are very popular, and it has been argued that the appeal of flavored ENDS products has fueled the rapid and spectacular growth of this industry 3, 5 . Thus, our objective was to investigate the in vitro and in vivo cardiac electrophysiological toxicity of flavorings in vaping. Our study showed that vaping results in cellular and whole organ electrophysiological toxicity that includes action potential instability and reduction in heart rate variability parameters. Therefore, although ENDS could be less harmful than traditional cigarette 33 , they are not harm free to the electrophysiological function of the heart.
In HL-1 mouse atrial cardiomyocytes 22 the 3 e-liquids tested were toxic, however to different extents, where aldehyde containing vanilla custard and apple jax flavors, as determined by GC-MS, were more detrimental compared to the fruity flavored e-liquid. This is independent of nicotine content, since these e-liquids are stated to contain 6 mg/ml nicotine.
These findings are consistent with similar studies conducted in many other cell lines, however, these cell lines are not relevant to cardiac electrophsyiology 11, 13-15, 17, 18 . Additionally, vaping reduced cellular respiration in HL-1 cells, where basal, ATP linked and maximal rates of oxygen consumption were significantly reduced, similarly to what has been reported with tobacco cigarette smoke in airway smooth muscle cells 34 . In spontaneously beating hiPSC derived ventricular cardiomyocytes, e-vapor increased the beating rate as well as the corrected field potential duration (a surrogate for the QTc interval) 35 , raising the possibility that vaping could be arrhythmogenic since in the heart, prolongation of the QT interval is associated with the development of fast ventricular rhythms that include tachycardia and fibrillation 36 .
HRV analysis revealed patterns of change indicative of sympathovagal disbalance in the control of the mouse heart due to vaping where LF was increased, HF was decreased and LF/HF ratio increased. These changes are in line with what has been shown in human subjects who use tobacco cigarettes and electronic cigarettes 30 . HF is considered an index of parasympathetic modulation of the heart rate, and LF is considered an index of sympathetic modulation, but the actual contribution of the sympathetic and parasympathetic systems to HRV parameters in normal and abnormal physiology are still being dissected 26 . Nevertheless, it is accepted that an increase in the LF to HF ratio of HRV is indicative of sympathovagal disbalance, and usually correlates with development of arrhythmias and poor cardiovascular outcome 26, 31 . This is in line with the in vivo VT inducibility studies which we conducted, where in vaped mice, inducible VT was more sustained compared to air control mice, and where in optical mapping, vaping resulted in action potential instability which manifested as action potential alternans.
In conclusion, our study is the first to show that vaping produces cardiac electrophysiological toxicity that include prolongation of the QT interval, reduced heart rate variability, inducibility of VT, and action potential alternans. The respiratory system is the major route of ENDS smoke entry into the body, and vaping related pulmonary illnesses are increasingly documented in the clinic 37 . However, similarly to combustible tobacco smoking, ENDS use could have potentially serious and harmful effects on the heart. Our work is the first demonstration that vaping compromises the cardiac electrophysiological integrity, and further studies are needed to further assess the long-term cardiac safety profile of ENDS products. 
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